Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Minerva Cardioangiol. 2020 Oct;68(5):405-414. doi: 10.23736/S0026-4725.20.05198-1. Epub 2020 Feb 26.
Left main coronary artery (LMCA) disease has been reported in up to 10% of all patients with coronary artery disease (CAD) and in the majority of cases are associated with severe three-vessel CAD. Among patients with chronic coronary syndrome revascularization of significant LMCA disease improves prognosis, while there is a debate about which revascularization strategy, CABG surgery or percutaneous coronary interventions to use. We do a review of the available evidence about the impact of LMCA lesions on patient prognosis according to CAD extension and clinical presentation, the outcome after percutaneous or surgical revascularization, the procedural challenges of LMCA PCI and the available armamentarium to optimally treat this relevant population.
左主干冠状动脉(LMCA)疾病在所有冠心病(CAD)患者中高达 10%,且在大多数情况下与严重的三血管 CAD 相关。在慢性冠状动脉综合征患者中,显著 LMCA 疾病的血运重建可改善预后,而对于使用哪种血运重建策略(冠状动脉旁路移植术或经皮冠状动脉介入治疗)存在争议。我们对现有证据进行了回顾,根据 CAD 范围和临床表现探讨了 LMCA 病变对患者预后的影响、经皮或手术血运重建后的结果、LMCA PCI 的操作挑战以及最佳治疗这一相关人群的现有手段。